LEVELS OF NITRIC OXIDE METABOLITES IN RATS WITH HEPATOPULMONARY SYNDROME

  • I. Ya. Krynytska
Keywords: hepatopulmonary syndrome, nitric oxide metabolites.

Abstract

Background. System of nitric oxide (NO), which consists of NO, and its metabolites, is very important for various biological processes. NO is signalling molecules and mediators of intracellular and intercellular interaction that causes relaxation of smooth muscles of blood vessel walls, inhibits platelet aggregation and their adherence, is involved in the transmission of nerve impulses, cell proliferation.
Objective. The aim of our research was to study the content of nitric oxide metabolites in blood serum and bronchoalveolar lavage, to substantiate their role in pathogenesis of hepatopulmonary syndrome in experiment.
Methods. The experiments were performed on 56 outbread male rats, 180-220 g in weight. The first experimental model of hepatopulmonary syndrome (HPS) was made by imposition of double ligature on common bile duct and its further dissection with a scalpel. The second experimental HPS model was made by 8-week intragastric administration of oil solution CCl4 (400 g per 1 L), 0.5 ml per 100 g of body weight on the first day of the experiment, 0.3 ml per 100 g on the third day of the experiment and then every third day until the end of the experiment 0.3 ml per 100 g. A mixture of corn flour, lard and cholesterol and alcohol solution was added to the standard diet of the rats.
Results. The total content of nitric oxide metabolites in blood serum of the rats of the experimental group No.1 (on the 31st day after the common bile duct ligation) was significantly increased in 3.9 times (p1<0,001) if compared with the control group №1. In the rats of the 2nd experimental group (with carbon tetrachloride induced cirrhosis) the total content of nitric oxide metabolites in blood serum also significantly increased in 3.1 times (p1<0,001). Comparison of nitric oxide metabolites content in blood serum and bronchoalveolar lavage, which directly indicated about the processes in lung tissue, was great importance.
Conclusions. So, in rats with experimental hepatopulmonary syndrome activation of nitroxydergic process by significant increase in nitric oxide metabolites in blood serum and bronchoalveolar lavage took place.

References

Boiarchuk OR. Vmist metabolitiv oksydu azotu ta prozapalnykh tsytokiniv u khvorykh iz hostroiu revmatychnoiu lykhomankoiu ta khronichnoiu revmatychnoiu khvoroboiu sertsia. Ukrainskyi revmatolohichnyi zhurnal 2010; 3 (41): 9-13.

Kozar VV, Kudria MIa, Ustenko NV, Nikishyna LE, Kravchenko SV. Vyznachennia kontsentratsii metabolitiv oksydu azotu v syrovattsi krovi. Laboratorna diahnostyka 2010; 3 (53): 14–16.

Marushchak MI. Nitroksyderhichni aspekty patohenezu hostroho urazhennia lehen v eksperymenti. Tuberkuloz, lehenevi khvoroby, VIL-infektsiia 2011; 3 (6): 69-73.

Sapatyi AL, Kupnovytska IH. Metabolichni osoblyvosti oksydu azotu u formuvanni endotelialnoi dysfunktsii za sertsevo-sudynnykh zakhvoriuvan. Liky Ukrainy 2008; 6 (122): 82–86.

Khara MR, Dorokhina AM. Oksyd azotu ta sertsevo-sudynna systema (ohliad literatury). Zdobutky klinichnoi i eksperymentalnoi medytsyny 2010; 1: 14–20.

Yachnyk AI, Humeniuk MI, Chopchyk AD. Fiziolohichni aspekty oksydu azotu pry porushenniakh lehenevoho krovoobihu ta rol L – arhininu v korektsii yoho syntezu. Ukrainskyi pulmonolohichnyi zhurnal 2008; 1: 40–44.

Vvedenskaia LS, Brehel LV, Horbachev VY. Yzmenenyia v nytroksyderhycheskoi systeme pry lehechnoi hypertenzyy u detei s vrozhdennymy porokamy serdtsa. Pedyatryia 2006; 2: 21–24.

Harbuzenko DV. Patofyzyolohycheskye mekhanyzmy y novye napravlenyia terapyy portalnoi hypertenzyy pry tsyrroze pecheny. Klyn perspektyvy hastroenterol hepatol 2010; 6: 11–20.

Denysenko SV, Kostenko VA. Yzmenenyia mytokhondryalnoho okyslenyia y fosforylyrovanyia v semennykakh belykh krys v uslovyiakh izbytochnoho postuplenyia v ykh orhanyzm nytrata natryia. Ukr byokhym zhurn 2003; 1: 101–103.

Yashchenko YuB, Buriak AH. Nereshennye voprosy yspolzovanyia oksyda azota v kachestve markera dyahnostyky y lechebnoho sredstva v neonatolohyy. Sovremennaia pedyatryia 2010; 4 (32): 97–100.

Carter EP, Sato K, Morio Y, McMurtry IF. Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. Am J Physiol Lung Cell Mol Physiol 2000; 279: 903–910.

Degano B, Mittaine M, Herve P et al. Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. European respiratory Journal 2009; 34(1): 138–144.

Delclaux C, Mahut B, Zerah-Lancner F et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002; 165: 332–337.

European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Council of Europe Strasbourg 1986; 123: 52.

Fallon MB, Abrams GA, McGrath JW et al. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Аm J Phisiol 1997; 272: 779–784.

Fallon MB. Mechanisms of pulmonary vascular complications of liver disease. Hepatopulmonary syndrome. J Clin Gastroenterol 2005; 39 (2): 138–142.

Gomez FP, Barbera JA, Roca J, Burgos F, Gistau C, Rodriguez-Roisin R. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 2006; 43: 1084–1091.

Guevara I, Iwanejko J, Dembinska-Kiec A. Determination of nitrite/nitrate in human biologica materia by he simple Griess reaction. Clin Chim Acta 1998; 274 (2): 177–188.

Rolla G, Brussino L, Colagrande P. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998; 129: 375–378.

Whittle B, Moncada S. Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis. Hepatology 1992; 16: 1089–1092.

Zhang HY, Han DW, Zhao ZF, Liu MS, Wu YJ, Chen XM. Multiple pathogenic factor-induced complications of cirrhosis in rats: A new model of hepatopulmonary syndrome with intestinal endotoxemia. World J Gastroenterology 2007; 13 (25): 3500–3507.

Zhang J, Ling Y, Luo B et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003; 125: 1441–1451.

Yaremchuk OZ, Posokhova KA. The liver and kidneys biochemical indices at the experimental pancreatitis in case of the administration of nitric oxide synthesis modulators and recombinant superoxide dismutase. The Ukrainian Biochemical Journal 2011; 83 (4): 57–66.

Published
2016-05-12
How to Cite
Krynytska, I. Y. (2016). LEVELS OF NITRIC OXIDE METABOLITES IN RATS WITH HEPATOPULMONARY SYNDROME. International Journal of Medicine and Medical Research, 2(1), 39-43. https://doi.org/10.11603/ijmmr.2413-6077.2016.1.6380